Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Organisation › Details

Brammer Bio LLC

Brammer Bio provides clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patients' health. Brammer is Helping to Cure®. Brammer is owned by Ampersand Capital Partners, the only institutional investor in the company, and its founders. *

 

Period Start 2017-12-09 existent
  Group Thermo Fisher (Group)
Product Industry  cell therapy
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 250 Binney Street
  City 02142 Cambridge, MA
    Address record changed: 2017-12-09
     
Basic data Employees E: 501 to 1,000 (2019-03-24)
  Currency USD
  Annual sales 250,000,000 (revenue, expected (2019) 2019-12-31)
     
    * Document for �About Section�: Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA.
     
   
Record changed: 2019-03-26

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Thermo Fisher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top